MArS is your hands-on consultancy with a strategic vision for the D-A-CH region – Germany, Austria, Switzerland.
We are committed to our clients’ commercial success and offer flexible solutions, for example by acting as a virtual market access team or by taking on or preparing specific tasks such as advising with payers, creating dossiers and conducting negotiations.
Our services are customer-oriented and customized, including direct contracting with individual payers.
With many years of experience and a strong team of consultants, MArS is the perfect partner for market access in Germany, Austria and Switzerland.
MArS levers the available innovative market access platforms mAxInsights®, DO-Bo and Wafle in order to make your activities in the D-A-CH region successful!
Germany
§ Creating dossiers for AMNOG submissions, evaluation committee, DiGA path and the like.
§ Preparation for and participation in G-BA consultation procedures and hearings, NUB application procedures, DIGA application procedures, as well as participation in price negotiations with the GKV-SV.
Austria
Preparation of dossiers for the umbrella organization, preparation for and participation in consultation procedures and hearings within the framework of the reimbursement code (EKO), as well as participation in price negotiations with Austrian social security or hospitals.
Switzerland
Preparation of dossiers for the BAG procedure and advice on inclusion in the specialty list.
In order to achieve the optimal price for your product, a detailed analysis by experienced experts of the D-A-CH market is required. The specifics of the product as well as the special features of the indication area must be taken into account.
Beyond planning, MArS also supports you in implementing the target price. When negotiating contracts and prices, it is not only a matter of clear and strategic communication but also of a well-defined and planned negotiation strategy. In order to secure a successful outcome, Wafle, our AI-driven VR platform, is being utilized with each client.
We offer services for creating and adapting health economic models.
Market access consulting
Our specialized consulting services support you in successfully registering and launching your products. With in-depth expertise in regulatory requirements, including procedures at, for example, BfArM and EMA, we guide you through the entire process – from strategic planning to a successful market launch. This includes direct interaction with the regulatory authorities to optimize the approval process, as well as support in preparing and submitting all the necessary documents for a successful approval.
Stakeholder engagement
We identify relevant stakeholders, including public authorities, health insurance companies and medical associations. We then hold digital or on-site advisory board meetings with them or conduct successful negotiations with them. With customized solutions, we conclude contracts for special care with health insurance companies, for example.
Whether in the AMNOG process for drugs or in specific reimbursement situations for diagnostics or medical devices; the clinical evidence must match the expectations and requirements of payers. In the German context, this will mainly be the focus of the statutory health insurances, while in Austria and Switzerland a mix of the main association and the individual health insurance funds. Study planning must take into account specifics of the clinical trial design and, above all, the correct choice of comparative therapy and clinical endpoints. Not every clinical endpoint is actually important in the D-A-CH countries. A planned study program can be optimized through early consultation with institutions, e.g. the Joint Federal Committee in Germany, and/or expert surveys including advisory boards. MArS can actively support you through its long-standing contacts and the MArS Payer Forum.
Additionally, direct contracts with payers in the the D-A-CH region can be initiated by early engagement and discussions with these institutions. These selective, direct or integrated care contracts can be the go-to-market strategy for medical devices and could also support pricing for pharmaceuticals.
A successful submission begins with a systematically elaborated submission and pricing strategy. This includes the screening of the market and the competitive situation as well as the evaluation and benchmarking of our own clinical and economic evidence. This should also include payer research and discussions with physicians and decision-makers, e.g. via advisory boards.
In any case, the key for success is the development of a high-quality submission dossier. MArS has already moved into Market Access 4.0 with its unique medical writing bot DO-Bo. DO-Bo could be utilized by clients on their own, but in addition to that, MArS also offers the support by experienced individuals in order to finalize the dossier after the availability of a DO-Bo dossier version. MArS can refer to the experience of many different submissions in the D-A-CH countries including drugs, medical devices, diagnostics and eHealth solutions (including apps).
Germany
§ Creating dossiers for AMNOG submissions, evaluation committee, DiGA path and the like.
§ Preparation for and participation in G-BA consultation procedures and hearings, NUB application procedures, DIGA application procedures, as well as participation in price negotiations with the GKV-SV.
Austria
Preparation of dossiers for the umbrella organization, preparation for and participation in consultation procedures and hearings within the framework of the reimbursement code (EKO), as well as participation in price negotiations with Austrian social security or hospitals.
Switzerland
Preparation of dossiers for the BAG procedure and advice on inclusion in the specialty list.
In order to achieve the optimal price for your product, a detailed analysis by experienced experts of the D-A-CH market is required. The specifics of the product as well as the special features of the indication area must be taken into account.
Beyond planning, MArS also supports you in implementing the target price. When negotiating contracts and prices, it is not only a matter of clear and strategic communication but also of a well-defined and planned negotiation strategy. In order to secure a successful outcome, Wafle, our AI-driven VR platform, is being utilized with each client.
We offer services for creating and adapting health economic models.
Market access consulting
Our specialized consulting services support you in successfully registering and launching your products. With in-depth expertise in regulatory requirements, including procedures at, for example, BfArM and EMA, we guide you through the entire process – from strategic planning to a successful market launch. This includes direct interaction with the regulatory authorities to optimize the approval process, as well as support in preparing and submitting all the necessary documents for a successful approval.
Stakeholder engagement
We identify relevant stakeholders, including public authorities, health insurance companies and medical associations. We then hold digital or on-site advisory board meetings with them or conduct successful negotiations with them. With customized solutions, we conclude contracts for special care with health insurance companies, for example.
© 2024 All Rights Reserved.
